As a clinician, researcher, and executive, Sofija is focused on applying research and innovation to transform the life science and healthcare industries. She is also passionate about the representation of women at executive and corporate governance levels and believes it to be one of the untapped sources of growth and transformation in business and science.
In 2007, Sofija co-founded ProPhase, a global specialty service firm that is focused on helping clinical stage companies de-risk their drug development programs. After leading ProPhase through a decade of profitable growth that transformed the company from a start-up to a market leader, she recently successfully completed the sale of ProPhase to a private equity portfolio company. She was the Managing Board Member at ProPhase and holds current Board appointments at CRA Assessments and Gilda’s Club of New York City.
Prior to transitioning into an executive career, she served in a variety of roles, including private practice, academia, and clinical research. She began her career as a clinical psychologist, teaching, conducting research and providing testing and treatment at a variety of treatment settings. She is a founding member of CNS Summit, as well as a member of The International Society for CNS Drug Development (ISCDD), Women in BIO, Women Entrepreneurs in Science and Technology (WEST), National Association of Corporate Directors (NACD), and Healthcare Businesswomen’s Association (HBA). She recently became a NACD Board Leadership™ Fellow and was selected as one of top 20 life science executives poised for Board service by Women in BIO Boardroom Ready program.